跳至主要内容
临床试验/NCT03601338
NCT03601338已完成早期 1 期

Second Generation Low Molecular Weight Heparin (Bemiparin) as a Prophylactic for Management of Subsequent Pregnancy After an Unexplained Stillbirth: A Clinical Comparative Study

Hawler Medical University1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2015年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
140
试验地点
1
主要终点
Stillbirth

研究概览

简要总结

Bemiparin for pregnant women with abnormal umbilical artery Doppler ultrasound

详细描述

152 women with history of unexplained stillbirths were identified , umbilical arty Doppler ultrasound was conducted for them at 20-22 weeks gestation . they were divided into two group , group one are those with abnormal resistant index (= or more than 0.6) thy received Bemiparin 2500 IU subcutaneously daily up to 24 hours before delivery .

Group 2 with normal umbilical artery resistant index received no any interventions just routine antenatal follow up .

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 44 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Second pregnancy after previous unexplained fetal death
  • Singleton pregnancy
  • No any medical disorders during pregnancy like diabetes or Systemic Lupus Erythematosus
  • Normally located placenta
  • No congenital fetal anomalies
  • Patient accept to participate

排除标准

  • Confirmed thrombophilia
  • Twin pregnancies
  • Refused to participate

研究组 & 干预措施

Bemiparin group

Active Comparator

Women with high resistant index of umbilical artery received the intervention Bemiparin Sodium 2,500 IU anti Xa/0.2 ml solution for injection in pre-filled syringe provided for each woman . The injections were received daily since 20 weeks gestation and up to 24 hours before delivery

Other Name: Hibor; Laboratories Rovi pharmaceuticals

干预措施: Bemiparin (Drug)

control group

Placebo Comparator

Normal umbilical arty resistant index group received only multivitamins and routine antenatal follow up

干预措施: multivitamins and routine antenatal follow up (Other)

结局指标

主要结局

Stillbirth

时间窗: after 20 weeks gestation to the delivery of fetus

Intrauterine fetal death

Early neonatal death

时间窗: First week of life

Death of newborn

Low birth weight

时间窗: first hour of life

New borne with birth weight less than 5th percentile in kilogram

次要结局

  • major abruptio placenta(20-41 week gestation)
  • Pre-eclampsia(20-41 week gestation)
  • Preterm labor(20-37 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shahla Alalaf

professor

Hawler Medical University

研究点 (1)

Loading locations...

相似试验

Low Molecular Weight Heparin in Pregnancies With... | 临床试验